Organisation paid for research Program year 2024 Source: CMS Open Payments

Amr Conventions Reasearch

Neither a doctor nor a teaching hospital

Research payments

$570,901

10 payments

Through program year 2024, Amr Conventions Reasearch is reported as receiving $570,901 in research payments, across 10 payments.

By program year

5 rows

Year	Kind	Amount	Payments
2024	Research	$7,062	1
2023	Research	$73,152	1
2022	Research	$161,411	2
2021	Research	$253,417	3
2020	Research	$75,860	3

Breakdown

Who paid Research payments · program years 2020–2024

Otsuka Pharmaceutical Development & Commercialization, Inc. $570,901 10 payments

Studies the money was for Research payments · program years 2020–2024

A Phase 3, Multicenter, Randomized, Double-Blind Trial of Fixed-Dose Brexpiprazole As Combination Therapy With Sertraline in the Treatment of Adults With Post-Traumatic Stress Disorder $270,326 3 payments
A Multicenter, Randomized, Flexible-Dose, Double Blind Trial of Brexpiprazole Versus Placebo for the Treatment of Adults With Borderline Personality Disorder $228,683 2 payments
A Multicenter, Open-label Trial to Evaluate the Safety and Tolerability of Brexpiprazole $39,349 2 payments
Brexpiprazole as Combination Therapy With Sertraline in the Treatment of Adults With Post-traumatic Stress Disorder $23,221 1 payment
A Phase 3, Multicenter, Randomized, Double-Blind Trial of Fixed-Dose Brexpiprazole As Combination Therapy With Sertraline in the Treatment of Adults With Post?Traumatic Stress Disorder $7,062 1 payment
A Multicenter, Open-Label Trial to Evaluate the Safety and Tolerability of Brexpiprazole in the Treatment of Subjects With Borderline Personality Disorder. $2,260 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.